If you don"t like change, you are going to like irrelevance even less.

http://type2diabetestreatment.net/diabetes-research/if-you-dont-like-change-you-are-going-to-like-irrelevance-even-less/

Diabetes patients have improved health outcomes with semaglutide, study finds A study in The Lancet Diabetes & Endocrinology showed that type 2 diabetes patients significantly reduced their A1C levels by 1.45% with 0.5 mg semaglutide and by 1.55% with 1.0 mg at week 30, compared with a non-significant reduction of 0.02% among those on placebo. Researchers evaluated 388 treatment-naive patients and found those on semaglutide also had significant reductions in body weight. Medscape (free registration)/Reuters (1/27) Study compares economic benefit of diabetes treatments Type 2 diabetes patients had an average one-year total cost reduction of $1,110 with statin-triglyceride-specific combination lipid therapy, compared with monotherapy or no lipid pharmacotherapy, with the greatest cost reduction seen among those who reduced their TG levels by at least 30%, according to a study in The American Journal of Cardiology. The findings, based on 184,932 patients, revealed those on statin monotherapy who reduced their TG levels by at least 30% also had a $1,079 reduction in adjusted costs. Physician"s Briefing/HealthDay News (1/27)

Inactivity may raise health risks regardless of weight (John Macdougall/AFP/Getty Images) A study in the American Journal of Preventive Medicine found about 25% of inactive adults who were at a healthy weight met criteria for prediabetes or diabetes, and the number increased to more than 40% for those ages 45 and older. University of Florida researcher Arch Mainous said the study suggests having a sedentary lifestyle is overlooked as a risk factor among people who are at a healthy weight. HealthDay News (1/27) Diet program helped limit pregnancy weight gain, study says Obese and overweight pregnant women who participated in a diet and lifestyle program gained less weight, but pregnancy outcomes were no different than for those who received usual care, according to a study presented at the Society for Maternal-Fetal Medicine"s annual meeting. Data showed 68% of women in the intervention group gained more weight than recommended by Institute of Medicine guidelines, compared with 86% of women in the usual care group. MedPage Today (free registration) (1/26) Gym membership linked to greater physical activity, data show A study in the journal PLOS ONE linked having a gym membership to a 14 times greater likelihood of meeting physical activity guidelines. Researchers said people who did not belong to a gym on average got 137 minutes of exercise per week, compared with an average of 484 minutes for gym members. Time.com (1/25)

Health care policy considerations for the senior boom As boomers age and the US senior population grows, health care policy changes should reflect patient preferences and needs; enact delivery system reforms based on robust evidence; account for social determinants of health; and ensure an adequate health care workforce with training in geriatric care, according to the American Geriatrics Society. BenefitsPro.com (1/24)

Study: Single fatty meal can lower insulin sensitivity, affect liver The Independent (London) (tiered subscription model) Mediterranean diet improves outcomes for diabetes patients, study says United Press International Omarigliptin, sitagliptin show comparable results as add-on to metformin Healio (free registration) Diabetes patients on insulin may benefit from using CGMs, studies find MedPage Today (free registration) Study: Diabetes patients have distinct gut inflammatory profile, microbiota Physician"s Briefing/HealthDay News

ACA repeal could force states to rewrite their budgets State budgets that don"t factor in a full repeal of the Affordable Care Act would need to be rewritten if President Donald Trump goes forward with plans to dismantle the program. A repeal would have the biggest effects on the 31 states that have expanded Medicaid under the health care law. Governing magazine online (1/23)

Apply now: Pathway to Stop Diabetes The call for nominations is now open for ADA"s Pathway to Stop Diabetes initiative. Pathway provides substantial support to exceptional scientists who are early in their diabetes research careers or who are established in other disciplines, but are interested in applying their expertise to diabetes research. Applications are by institutional nomination only and are due July 3. Learn more and apply. Learn more about DiabetesPro: DiabetesPro Home | Professional Education | Journals Research Grants | Recognition Programs | Membership

Press Releases FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery Post a Press Release

If you don"t like change, you are going to like irrelevance even less. Eric Shinseki, military leader

Type 2 Diabetes Treatment
Type 2 Diabetes Diet
Diabetes Destroyer Reviews
Original Article
#Diabetes_Research
#obesity_help